You are using an older browser version. Please use a supported version for the best MSN experience.

U.S. strikes deal with Lilly for potential COVID-19 antibody drug

The U.S. government will pay as much as $1.19 billion to Eli Lilly and Co to secure nearly 1 million doses of its experimental COVID-19 antibody treatment. This report produced by Yahaira Jacquez.

UP NEXT

UP NEXT

More From Reuters

image beaconimage beaconimage beacon